Seasoned Executive with Proven Track Record of Value Creation in Life Sciences RADNOR, Pa. , July 21, 2025 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, today announced that it has named Emmanuel Ligner, President and Chief Executive Officer, effective August 18, 2025.

CNBC's Andrew Ross Sorkin reports on the latest news.

RICHMOND, Calif. , July 21, 2025 /PRNewswire/ -- Octillion Power Systems ("Octillion", or the "Company"), a California-based global-leading supplier of advanced high-density lithium-ion battery packs for electric vehicles of all types—today announced that it has expanded its existing partnership with Vision Marine Technologies Inc. (NASDAQ: VMAR) ("Vision") to produce high-voltage lithium-ion battery packs for their marine propulsion systems from Octillion's Reno, Nevada manufacturing facility.

LOS ANGELES , July 21, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against 3D Systems Corporation ("3D Systems" or "the Company") (NYSE: DDD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 13, 2024 and May 13, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 12, 2025.

Microsoft urges immediate patching of SharePoint servers after zero-day cyberattacks, with on-premises 2016/2019 editions at risk but cloud versions unaffected. London Stock Exchange considers 24-hour trading to meet rising retail investor demand, joining global peers evaluating extended market hours.

Gold prices are up about 25% this year as investors seek a safe haven from trade war anxieties and geopolitical tensions. High-net-worth Americans are increasingly turning to physical gold to diversify from the depreciating U.S. dollar, according to Stephen Jury of J.P.

RESEARCH TRIANGLE PARK, N.C., July 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its second quarter 2025 financial results on Monday, August 4, 2025.

IND cleared for the EVERLAST-A Phase 2a trial of ORKA-001 in moderate-to-severe psoriasis, with initial data expected 2H 2026

Agrees to issue approximately $10 Million Convertible Notes at $13 per share, a 198% premium to July 18 close $189 million raised year-to-date through hallmark DeFi/TradFi Accretion Flywheel strategy SILVER SPRING, MD, July 21, 2025 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, short for Blockchain Technology Consensus Solutions, today announced that the combined market value of its 55,788 ETH holdings, cash1, and other liquid holdings are approximately $242.2 million, based on an ETH price of $3,600. Additionally, the Company has agreed to issue $10 million in convertible notes through its previously established …

NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced positive outcome from the PoNS (Portable Neuromodulation Stimulator) Stroke Registrational Program (SRP) supporting a planned FDA submission seeking an indication for gait and balance deficit in patients with chronic symptoms of stroke under the current Breakthrough Device Designation.

Nokia CorporationStock Exchange Release21 July 2025 at 14:00 EEST Changes in Nokia Corporation's own shares Espoo, Finland – A total of 11 148 Nokia shares (NOKIA) held by the company were transferred today without consideration to participants of Nokia's equity-based incentive plans in accordance with the rules of the plans. The transfer is based on the resolution of the Board of Directors to issue shares held by the company to settle its commitments to participants of the plans as announced on 22 November 2024. The number of own shares held by Nokia Corporation following the transfer is 64 685 389.

TORONTO, July 21, 2025 (GLOBE NEWSWIRE) -- Rogers Communications Inc. (“Rogers” or the “Company”) (TSX: RCI.A and RCI.B; NYSE: RCI) announced (i) the release of the results of its previously announced eight separate offers (the “Offers”) to purchase for cash any and all of the outstanding notes of each series listed in the table below (collectively, the “Notes”), and (ii) that Rogers is increasing the aggregate Total Consideration payable for all Notes it will accept for purchase in the Offers, excluding accrued but unpaid interest, from the previously announced amount of US$1,250,000,000 to US$1,400,000,000 (the “Consideration Cap Amount”). The increased …

MRT-8102 Phase 1 study includes single and multiple ascending dose cohorts in healthy volunteers and is designed to evaluate safety, pharmacokinetics, NEK7 protein degradation, and other key downstream pharmacodynamic markers; initial results anticipated in H1 2026 Additional Phase 1 cohort designed to evaluate potential early proof of concept in subjects with increased cardiovascular disease (CVD) risk and elevated CRP BOSTON, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced that the first subjects have been dosed in a Phase 1 study evaluating MRT-8102, …

DALLAS, July 21, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced the separation of the roles of Chairman of the Board of Directors (“Board”) and Chief Executive Officer with the appointment of Thomas O. Hicks as Chairman of the Board and James G.

Company focused on obtaining approval for outpatient (at-home) use of IGALMI® for the acute treatment of agitation associated with bipolar disorders or schizophrenia

PALO ALTO, Calif.--(BUSINESS WIRE)--D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave” or the “Company”), a leader in quantum computing systems, software, and services, and the world's first commercial supplier of quantum computers, announced the results of a new study today that highlights the potential for quantum optimization to create value across industries. According to the study, 46% of surveyed business leaders whose company has implemented quantum optimization or plans to do so within the next.

SAN FRANCISCO--(BUSINESS WIRE)--ON24 (NYSE: ONTF) will release its second quarter 2025 financial results after U.S. markets close on Thursday, August 7, 2025. ON24 management will host a conference call and webcast that day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss its business and financial performance. Event: ON24 Second Quarter 2025 Earnings Call Date: Thursday, August 7, 2025 Time: 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time Webcast: investors.ON24.com Dial-i.

HERNDON, Va.--(BUSINESS WIRE)---- $BKSY #earnings--BlackSky Technology Inc. (NYSE: BKSY) will host a conference call to discuss second quarter 2025 financial results and its business outlook on Thursday, August 7, 2025, at 8:30 a.m. EDT. A press release with BlackSky's financial results will be released in advance of the conference call that same day. To access the live webcast or the archived webcast following completion of the call, please click here or visit the company's investor relations website at http://ir.

DENVER--(BUSINESS WIRE)--BKV Corporation (“BKV” or the “Company”) (NYSE: BKV) today announced the execution of an agreement with a leading diversified midstream energy company to develop a new carbon capture and sequestration (“CCS”) project at a currently operating natural gas processing plant in East Texas. The agreement expands on a previously announced agreement between the companies to develop a separate CCS project at a location in South Texas. The new CCS project will be constructed on t.

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that positive results from the Phase 3 OASISplus prospective switch study of donidalorsen in patients with hereditary angioedema (HAE) were published in The Journal of Allergy and Clinical Immunology (JACI) In Practice. Results indicate that patients who switched to donidalorsen from prior prophylactic treatments showed a 62% further reduction in mean monthly HAE attack rate from baseline, and 84% of p.